Healixa Inc.
EMOR · OTC
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $389 | $92 | $389 | $128 |
| % Growth | 323.6% | -76.4% | 204.1% | – |
| Cost of Goods Sold | $121 | $80 | $121 | $119 |
| Gross Profit | $268 | $12 | $268 | $9 |
| % Margin | 69% | 12.6% | 69% | 6.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $242 | $153 | $242 | $187 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $242 | $153 | $242 | $187 |
| Operating Income | $27 | -$142 | $27 | -$178 |
| % Margin | 6.9% | -154.3% | 6.9% | -139.5% |
| Other Income/Exp. Net | -$78 | $0 | -$78 | -$33 |
| Pre-Tax Income | -$51 | -$142 | -$51 | -$212 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$51 | -$142 | -$51 | -$212 |
| % Margin | -13.2% | -154.3% | -13.2% | -165.5% |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | 50% | -100% | 66.7% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 766,647 | 766,647 | 766,647 | 766,570 |
| Weighted Avg Shares Out Dil | 766,647 | 766,647 | 766,647 | 766,570 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $78 | $0 | $78 | $102 |
| Depreciation & Amortization | $11 | $0 | $3 | $8 |
| EBITDA | $38 | -$142 | $30 | -$170 |
| % Margin | 9.7% | -154.3% | 7.6% | -133% |